Poly(C)-binding protein 1 mediates drug resistance in colorectal cancer

Oxaliplatin (L-OHP) is standard treatment for colorectal cancer. However, resistance to L-OHP often leads to treatment failure or cancer relapse. Understanding of the mechanism underlying L-OHP resistance is important to overcome the resistance and improve colorectal cancer treatment. This study aim...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Guo, Jiani, Zhu, Changli, Yang, Kangqun, Li, Jin, Du, Nan, Zong, Mingzhu, Zhou, Jianwei, He, Jingdong
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355098/
https://ncbi.nlm.nih.gov/pubmed/28076324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14516
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars